209 related articles for article (PubMed ID: 19717523)
1. Eosinophil ribonucleases and their cutaneous lesion-forming activity.
Plager DA; Davis MD; Andrews AG; Coenen MJ; George TJ; Gleich GJ; Leiferman KM
J Immunol; 2009 Sep; 183(6):4013-20. PubMed ID: 19717523
[TBL] [Abstract][Full Text] [Related]
2. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
[TBL] [Abstract][Full Text] [Related]
3. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
4. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis.
Johansson O; Liang Y; Marcusson JA; Reimert CM
Arch Dermatol Res; 2000 Aug; 292(8):371-8. PubMed ID: 10994770
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.
Motojima S; Frigas E; Loegering DA; Gleich GJ
Am Rev Respir Dis; 1989 Mar; 139(3):801-5. PubMed ID: 2923379
[TBL] [Abstract][Full Text] [Related]
7. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes.
Sur S; Glitz DG; Kita H; Kujawa SM; Peterson EA; Weiler DA; Kephart GM; Wagner JM; George TJ; Gleich GJ; Leiferman KM
J Leukoc Biol; 1998 Jun; 63(6):715-22. PubMed ID: 9620664
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil granule proteins in peripheral blood granulocytes.
Abu-Ghazaleh RI; Dunnette SL; Loegering DA; Checkel JL; Kita H; Thomas LL; Gleich GJ
J Leukoc Biol; 1992 Dec; 52(6):611-8. PubMed ID: 1464733
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.
Gleich GJ; Loegering DA; Bell MP; Checkel JL; Ackerman SJ; McKean DJ
Proc Natl Acad Sci U S A; 1986 May; 83(10):3146-50. PubMed ID: 3458170
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of an antitumor ribonuclease to Purkinje neurons.
Newton DL; Walbridge S; Mikulski SM; Ardelt W; Shogen K; Ackerman SJ; Rybak SM; Youle RJ
J Neurosci; 1994 Feb; 14(2):538-44. PubMed ID: 8301353
[TBL] [Abstract][Full Text] [Related]
12. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni.
Ackerman SJ; Gleich GJ; Loegering DA; Richardson BA; Butterworth AE
Am J Trop Med Hyg; 1985 Jul; 34(4):735-45. PubMed ID: 4025686
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis.
Tischendorf FW; Brattig NW; Burchard GD; Kubica T; Kreuzpaintner G; Lintzel M
Acta Trop; 1999 Mar; 72(2):157-73. PubMed ID: 10206116
[TBL] [Abstract][Full Text] [Related]
16. The production of the eosinophil proteins ECP and EPX/EDN are regulated in a reciprocal manner.
Jönsson UB; Blom K; Stålenheim G; Håkansson LD; Venge P
APMIS; 2014 Apr; 122(4):283-91. PubMed ID: 24738159
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil granule proteins are selective activators of human heart mast cells.
Patella V; de Crescenzo G; Marino I; Genovese A; Adt M; Gleich GJ; Marone G
Int Arch Allergy Immunol; 1997; 113(1-3):200-2. PubMed ID: 9130522
[TBL] [Abstract][Full Text] [Related]
18. Genetic and shared environmental risk factors do not lead to eosinophil activation in healthy twins of IBD patients.
Halfvarson J; Ling Lundström M; Lampinen M; Schoultz I; Bodin L; Carlson M
Scand J Gastroenterol; 2020 Oct; 55(10):1163-1170. PubMed ID: 32815414
[TBL] [Abstract][Full Text] [Related]
19. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology.
Trocmé SD; Hallberg CK; Gill KS; Gleich GJ; Tyring SK; Brysk MM
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):593-9. PubMed ID: 9071212
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytes.
Amber KT; Chernyavsky A; Agnoletti AF; Cozzani E; Grando SA
Exp Dermatol; 2018 Dec; 27(12):1322-1327. PubMed ID: 30218612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
